Key Takeaways
- • UC Davis launched a $25 million Investing in the Future of Medicine Fund in April 2025 to finance life sciences and healthcare spinouts, marking the university's first direct equity investment mechanism in its own companies.
- • HM Ventures, a San Francisco-based venture capital firm, is a partner in the healthcare fund and sits on its investment committee; UC Davis is actively recruiting additional VC firms and corporate investors.
- • The university signed a deal with The March Group (Davis, California-based VC firm) to establish a food and health accelerator and associated $10 million food and health spinout investment fund.
- • UC Davis is departing from its historical strategy of generating revenues primarily through technology licensing, instead taking equity stakes in spinout companies as part of a broader shift toward sector-specific investment funds.
- • This initiative reflects a broader trend among US universities launching their own investment funds as traditional government funding declines under the current administration.
Summary
University of California, Davis is fundamentally shifting its approach to commercializing university research by launching sector-specific spinout investment funds and deepening partnerships with venture capital firms. Historically, UC Davis relied on technology licensing revenues rather than taking equity positions in spinout companies. The university's new strategy represents a material departure from this model, driven partly by declining government funding support under the current US administration.
The centerpiece of this initiative is the Investing in the Future of Medicine Fund, a $25 million vehicle launched in April 2025 to support life sciences and healthcare startups created in UC Davis laboratories. This marks the university's first dedicated mechanism for direct equity investment in its own companies. HM Ventures, a San Francisco-based venture capital firm, serves as a fund partner and holds a seat on the investment committee. George Baxter, UC Davis's chief innovation and economic development officer, underscored the strategic importance: "We've never had a mechanism for investment into our own companies. This Investing in Future Medicine Fund will allow us to do that for the first time."
UC Davis is actively recruiting additional venture capital firms and industrial partners to co-invest in the healthcare fund while simultaneously building out complementary sector-specific vehicles. The university has signed an agreement with The March Group, a Davis-based venture capital firm, to create a food and health accelerator at the university campus and launch an associated $10 million food and health spinout investment fund. These funds will target spinouts in food and health sectors specifically. The university's proximity to the Bay Area venture ecosystem, despite historical reliance on licensing models, positions it to attract institutional capital and operational expertise from established VC partners.
The centerpiece of this initiative is the Investing in the Future of Medicine Fund, a $25 million vehicle launched in April 2025 to support life sciences and healthcare startups created in UC Davis laboratories. This marks the university's first dedicated mechanism for direct equity investment in its own companies. HM Ventures, a San Francisco-based venture capital firm, serves as a fund partner and holds a seat on the investment committee. George Baxter, UC Davis's chief innovation and economic development officer, underscored the strategic importance: "We've never had a mechanism for investment into our own companies. This Investing in Future Medicine Fund will allow us to do that for the first time."
UC Davis is actively recruiting additional venture capital firms and industrial partners to co-invest in the healthcare fund while simultaneously building out complementary sector-specific vehicles. The university has signed an agreement with The March Group, a Davis-based venture capital firm, to create a food and health accelerator at the university campus and launch an associated $10 million food and health spinout investment fund. These funds will target spinouts in food and health sectors specifically. The university's proximity to the Bay Area venture ecosystem, despite historical reliance on licensing models, positions it to attract institutional capital and operational expertise from established VC partners.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.